User: Genecampaign Topic: IP
Category: patents :: everywhere
Last updated: Jul 06 2015 13:02 IST RSS 2.0
 
1 to 20 of 10,061    
Lee Pharma wants licence for AstraZeneca's diabetes drug 6.7.2015 ET: Pharma
Lee Pharma filed the application on June 29 to make a generic version of the patented drug, marketed as Onglyza, under Section 84 of the Patent's Act, 1970.
Also found in: [+]
Delhi High Court upholds BMS’ patent for cancer drug Dasatinib 6.7.2015 ET: Pharma
The Indian Patent Office had in 2013 rejected the company’s demand for a compulsory licence as it did not follow the procedures for obtaining a voluntary licence.
Also found in: [+]
Indian company seeks compulsory nod for MNC’s drug 6.7.2015 TOI: India Business
A little-known Hyderabad-based pharma company has filed an application with the Patent Office to manufacture saxagliptin, a diabetes drug patented and marketed in the country by MNC AstraZeneca.
Also found in: [+]
Matti Makkonen: Father of SMS passes away 4.7.2015 Rediff: Business
Makkonen never received any money from the invention of text messaging, never applied for a patent
Also found in: [+]
MPP doubles its generic partners, adds more domestic drug firms 1.7.2015 TOI: Cities
The Medicines Patent Pool (MPP) announced the expansion of its network of generic manufacturers to 14 companies now working on over 50 projects to develop MPP-licensed antiretrovirals ...
Also found in: [+]
Glenmark gets US regulator nod for cholesterol drug 30.6.2015 Sify Finance
India's leading new molecules maker Glenmark Pharmaceuticals has received approval from the US Food and Drug Administration (USFDA) for its cholesterol-lowering drug Ezetimibe.
Also found in: [+]
Suven Life Sciences gets patents from Israel, South Africa and Japan for neurological drug 30.6.2015 ET: Pharma
Suven Life Sciences today said it has been granted a patent by Israel, Japan and South Africa for a drug used to treat neuro-degenerative diseases.
Also found in: [+]
Google's smart contact lens may arrive sooner than thought 28.6.2015 DNA: Recent Columns
Google's smart contact lens that will measure glucose levels in diabetics by analysing their tears may be on the market before 2019. In a recent patent application, Google showed off potential designs for how it could package a smart contact lens, suggesting the project could be further along than thought. Last year, the company announced that it was working on a lens that would be able to measure a wearer's glucose levels by analysing their tears. The lens could potentially remove the need for diabetics to prick their fingers and draw blood to check their blood-sugar levels. Google has previously said that general availability of the contact lens is most likely at least five years away. However, for a project that is supposedly in the research phase, it seems an interesting step to apply for a patent on how to package the product for consumers, according to Quartz. A representative for Google said that product releases can not be inferred from patent applications.  Report Sci/Tech PTI Washington dnatech ...
Also found in: [+]
Registration for muga traders, artisans stressed 25.6.2015 The Assam Tribune
Registration for muga traders, artisans stressed
Also found in: [+]
TAKE Solutions secures patent for clinical data standardization process 25.6.2015 TOI: Cities
TAKE Solutions -- a Chennai-based global business technology solutions provider -- has been awarded a patent by the United States Patent and Trademark Office (USPTO) for its clinical data standardization ...
Also found in: [+]
India, Japan to sign pact on increasing industrial property cooperation 24.6.2015 ET: Foreign Trade
The Memorandum of Cooperation will be signed between the Department of Industrial Policy and Promotion (DIPP) and the Japan Patent Office (JPO).
Also found in: [+]
Prominent Indian scientist denied US visa to attend conference in Ohio 24.6.2015 DNA: Wide Angle
Head of the Council of Scientific and Industrial Research (CSIR) Dr MO Garg is outraged that his visa to the US was denied, keeping him from attending a conference held in Columbus, Ohio on June 15. Dr Garg is in charge of the civilian research organisation which has 38 labs across the country. He submitted his passport to the US Embassy in Delhi almost 20 days ago in order to attend the conference but has yet to receive his passport back, NDTV reported. The scientist has travelled to the US several times since 1983. Six of his 30 patents are registered in the US. This is not the first time one of the countries eminent scientist has been denied a US visa. In 2006, the US was forced to apologise after denying a visa to Dr Goverdhan Mehta, the then Director of the Indian Institute of Science from Bengaluru.  When they interviewed Mehta for his visa, US embassy officials questioned the validity of his research. Image for representational purposes only.Getty ...
Also found in: [+]
Memorandum of Cooperation for bilateral cooperation in the field of Industrial Property for capacity building, human resource development and awareness generation between India and Japan 24.6.2015 Govt of india: PIB
The Union Cabinet chaired by the Prime Minister, Shri Narendra Modi, today gave its approval for signing of a Memorandum of Cooperation (MoC) between the Department of Industrial Policy & Promotion (DIPP) and the Japan Patent Office (JPO),
Also found in: [+]
Sensex edges higher, looks set to cross 28,000 mark again 24.6.2015 Sify Finance
Also found in: [+]
Focus on data privacy laws to boost medical outsourcing 23.6.2015 ET: Healthcare
The government should introduce proper regulations for intellectual property and patents besides focusing on implementing data privacy laws, a study said.
Also found in: [+]
BlackBerry quarterly software revenue jumps, shares climb 23.6.2015 Sify Finance
By Euan Rocha
Also found in: [+]
US Supreme Court judge quotes Spider-Man in toy dispute case against Marvel 23.6.2015 DNA: Top News
Invoking a famous line from Spider-Man lore about great power coming with great responsibility, the US Supreme Court ruled on Monday in favor of Marvel Entertainment LLC in a patent dispute over a toy that allows users, like the superhero, to shoot webs from the palms of their hands. Justice Elena Kagan cited the line in explaining why the court, in a 6-3 ruling, declined to overrule a 51-year-old legal precedent concerning patent royalties, rejecting a bid for continued payments sought by the toy's inventor. The court backed Walt Disney Co's Marvel Entertainment in its legal fight with Stephen Kimble and an associate, Robert Grabb, over royalties on the web-shooting toy called the Spider-Man Web Blaster. "Marvel is pleased with the Supreme Court's decision, which upholds the court's legal precedent from half a century ago," company spokesman David Jefferson said. Although the court can overturn its own precedents, this case did not warrant it, Kagan said. "What we can decide, we can undecide," Kagan ...
Also found in: [+]
Single-window clearance for pharma sector on anvil: Union Minister Ananth Kumar 23.6.2015 DNA: Mumbai
To enable a single-window clearance system in pharmaceuticals sector, the government will set up a high-level committee next week to work out the modalities for the same. The committee will be headed by Pharmaceuticals Secretary V K Subburaj and the move follows a recommendation by the task force on enabling the private sector to lead the growth of the pharmaceuticals sector. "It (committee) will suggest a mechanism for single-window clearance for the pharmaceuticals industry," Chemicals and Fertiliser Minister Ananth Kumar told PTI. Stressing on the importance of having a single authority for clearance in the sector, he said key decision-making powers on various important aspects such "patents, licencing and pricing are with different departments". While the issue of patents is dealt by Department of Industrial Policy & Promotion, drug licence is given by Drug Controller General of India under Health Ministry and pricing is controlled by NPPA, under Pharmaceuticals Department. "This coordination ...
Also found in: [+]
Deadmau5 and Walt Disney settle mouse ears legal dispute 23.6.2015 The Guardian -- Front Page

Canadian DJ Joel Zimmerman has settled a dispute with Disney over the similarities between his stage headwear and Mickey Mouse

Burn not your house to fright the mouse away. Deadmau5 and the Walt Disney Corporation have settled a legal dispute that has lasted almost a year over the “trademark” mouse head that Deadmau5 wears on stage.

Related: Deadmau5 v Disney: mouse ear logo sparks legal dispute

Continue reading...
Also found in: [+]
Single-window clearance for pharma sector on anvil: Ananth Kumar 22.6.2015 ET: Policy
To enable a single-window clearance system in pharma sector, govt will set up a high-level committee next week to work out the modalities for the same.
Also found in: [+]
1 to 20 of 10,061